{"entity":{"type":"insider","cik":"0001791857","url":"/insider/0001791857","json_url":"/insider/0001791857.json","name":"Jenne Kyle","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":6,"first":"2020-03-25","last":"2026-04-17","span_basis":"filed_date"},"name_variants":[{"name":"Jenne Kyle","source":"filing","n_filings":6,"first_seen":"2020-03-25","last_seen":"2026-04-17"}],"transactions":[{"id":5914554,"accession":"0000874015-26-000171","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-26-000171","line_url":"/filing/0000874015-26-000171#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001791857","owner_name":"Jenne Kyle","owner_display_name":"Jenne Kyle","owner_url":"/insider/0001791857","role":"Officer (EVP, Chf GL Pdt Str Ofcr)","role_mark":"O","role_mark_label":"Officer (EVP, Chf GL Pdt Str Ofcr)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chf GL Pdt Str Ofcr","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4902.0,"shares_display":"4,902","price_per_share":75.171,"price_display":"75.17","price_state":"stated","total_value":368488.242,"total_display":"368,488.24","total_whole":"368,488","shares_owned_after":23713.0,"shares_owned_after_display":"23,713","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-16","filed_date":"2026-04-17","scope":"insider"},{"id":5914548,"accession":"0000874015-26-000142","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000874015-26-000142","line_url":"/filing/0000874015-26-000142","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001791857","owner_name":"Jenne Kyle","owner_display_name":"Jenne Kyle","owner_url":"/insider/0001791857","role":"Officer (EVP, Chf GL Pdt Str Ofcr)","role_mark":"O","role_mark_label":"Officer (EVP, Chf GL Pdt Str Ofcr)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chf GL Pdt Str Ofcr","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37277.0,"shares_display":"37,277","price_per_share":75.84635786141588,"price_display":"75.85","price_state":"stated","total_value":2827324.682,"total_display":"2,827,324.68","total_whole":"2,827,325","shares_owned_after":27800.0,"shares_owned_after_display":"27,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-10","filed_date":"2026-03-11","scope":"insider","n_lines":2},{"id":5936757,"accession":"0000874015-26-000066","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-26-000066","line_url":"/filing/0000874015-26-000066#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001791857","owner_name":"Jenne Kyle","owner_display_name":"Jenne Kyle","owner_url":"/insider/0001791857","role":"Officer (EVP, Chf GL Pdt Str Ofcr)","role_mark":"O","role_mark_label":"Officer (EVP, Chf GL Pdt Str Ofcr)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chf GL Pdt Str Ofcr","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1823.0,"shares_display":"1,823","price_per_share":75.96,"price_display":"75.96","price_state":"stated","total_value":138475.08,"total_display":"138,475.08","total_whole":"138,475","shares_owned_after":16389.0,"shares_owned_after_display":"16,389","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-16","filed_date":"2026-01-20","scope":"insider"},{"id":4521913,"accession":"0000874015-25-000119","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-25-000119","line_url":"/filing/0000874015-25-000119#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001791857","owner_name":"Jenne Kyle","owner_display_name":"Jenne Kyle","owner_url":"/insider/0001791857","role":"Officer (EVP, Chf GL Pdt Str Ofcr)","role_mark":"O","role_mark_label":"Officer (EVP, Chf GL Pdt Str Ofcr)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chf GL Pdt Str Ofcr","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3016.0,"shares_display":"3,016","price_per_share":28.36,"price_display":"28.36","price_state":"stated","total_value":85533.76,"total_display":"85,533.76","total_whole":"85,534","shares_owned_after":11199.0,"shares_owned_after_display":"11,199","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-16","filed_date":"2025-04-17","scope":"insider"},{"id":2557950,"accession":"0001209191-20-051891","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-051891","line_url":"/filing/0001209191-20-051891#line-1","is_derivative":false,"issuer_cik":"0001662524","issuer_name":"AKCEA THERAPEUTICS, INC.","issuer_ticker":"AKCA","issuer_name_source":null,"issuer_url":"/issuer/0001662524","owner_cik":"0001791857","owner_name":"Jenne Kyle","owner_display_name":"Jenne Kyle","owner_url":"/insider/0001791857","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":720.0,"shares_display":"720","price_per_share":18.12,"price_display":"18.12","price_state":"stated","total_value":13046.4,"total_display":"13,046.40","total_whole":"13,046","shares_owned_after":52012.0,"shares_owned_after_display":"52,012","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-22","filed_date":"2020-09-24","scope":"insider"},{"id":3196543,"accession":"0001209191-20-021122","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-021122","line_url":"/filing/0001209191-20-021122#line-1","is_derivative":false,"issuer_cik":"0001662524","issuer_name":"AKCEA THERAPEUTICS, INC.","issuer_ticker":"AKCA","issuer_name_source":null,"issuer_url":"/issuer/0001662524","owner_cik":"0001791857","owner_name":"Jenne Kyle","owner_display_name":"Jenne Kyle","owner_url":"/insider/0001791857","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":779.0,"shares_display":"779","price_per_share":11.7503,"price_display":"11.75","price_state":"stated","total_value":9153.4837,"total_display":"9,153.48","total_whole":"9,153","shares_owned_after":52732.0,"shares_owned_after_display":"52,732","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-23","filed_date":"2020-03-25","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":7,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000874015","name":"IONIS PHARMACEUTICALS INC","url":"/issuer/0000874015","role":"Officer (EVP, Chf GL Pdt Str Ofcr)","n_filings":4,"first_seen":"2025-04-17","last_seen":"2026-04-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001662524","name":"AKCEA THERAPEUTICS, INC.","url":"/issuer/0001662524","role":"Officer (Chief Commercial Officer)","n_filings":2,"first_seen":"2020-03-25","last_seen":"2020-09-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001791857","retrieved_at":"2026-08-24T05:10:59+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}